$TLCC
Twinlab Consolidated Holdings Inc Stock $tlcc

$tlcc Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000175392623000347 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$9.023M	$9.338M	$52.58M
YoY Change	-31.91%	-42.53%	-27.06%
Cost Of Revenue	$6.811M	$6.470M	$38.24M
YoY Change	-22.8%	-63.38%	-31.11%
Gross Profit	$2.212M	$2.868M	$14.34M
YoY Change	-50.06%	-302.11%	-13.48%
Gross Profit Margin	24.52%	30.71%	27.28%
Selling, General & Admin	$2.935M	$3.830M	$15.98M
YoY Change	-26.48%	147.58%	21.46%
% of Gross Profit	132.69%	133.54%	111.37%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$12.00K	$43.00K	$52.00K
YoY Change	-70.0%	-59.43%	-35.0%
% of Gross Profit	0.54%	1.5%	0.36%
Operating Expenses	$2.935M	$3.830M	$15.98M
YoY Change	-26.48%	147.58%	21.46%
Operating Profit	-$723.0K	-$962.0K	-$1.971M
YoY Change	-265.45%	-67.57%	-74.38%
Interest Expense	$2.117M	-$2.026M	$7.902M
YoY Change	15.24%	1.71%	-8.23%
% of Operating Profit
Other Income/Expense, Net	-$2.087M	$0.00	-$6.226M
YoY Change	1196.27%	-100.0%	-552.47%
Pretax Income	-$2.810M	-$3.328M	-$8.197M
YoY Change	-1118.12%	-78.11%	-45.09%
Income Tax	$0.00	$25.00K	$25.00K
% Of Pretax Income
Net Earnings	-$2.810M	-$3.353M	-$8.222M
YoY Change	-1118.12%	-77.97%	-44.97%
Net Earnings / Revenue	-31.14%	-35.91%	-15.64%
Basic Earnings Per Share	-$0.01		-$0.03
Diluted Earnings Per Share	-$0.01	-$0.01	-$0.03
COMMON SHARES
Basic Shares Outstanding	259.1M shares	259.1M shares	259.1M shares
Diluted Shares Outstanding	259.1M shares		259.1M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$101.0K	$868.0K	$868.0K
YoY Change	-94.26%	-76.09%	-76.09%
Cash & Equivalents	$101.0K	$868.0K
Short-Term Investments
Other Short-Term Assets	$1.463M	$758.0K	$758.0K
YoY Change	104.9%	-27.46%	-27.46%
Inventory	$7.461M	$9.407M	$9.407M
Prepaid Expenses
Receivables	$2.393M	$4.105M	$4.105M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$11.42M	$15.14M	$15.14M
YoY Change	-31.16%	-12.85%	-12.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$117.0K	$188.0K	$4.353M
YoY Change	-13.33%	34.29%	-22.54%
Goodwill
YoY Change
Intangibles	$120.0K	$120.0K
YoY Change	-78.06%	-79.17%
Long-Term Investments
YoY Change
Other Assets	$1.301M	$1.301M	$1.301M
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Assets	$5.471M	$5.774M	$5.774M
YoY Change	-24.29%	-22.98%	-22.98%
TOTAL ASSETS
Total Short-Term Assets	$11.42M	$15.14M	$15.14M
Total Long-Term Assets	$5.471M	$5.774M	$5.774M
Total Assets	$16.89M	$20.91M	$20.91M
YoY Change	-29.08%	-15.91%	-15.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.964M	$6.621M	$6.621M
YoY Change	106.23%	9.49%	9.49%
Accrued Expenses	$37.92M	$36.28M	$36.28M
YoY Change	15.51%	16.49%	16.49%
Deferred Revenue	$2.019M	$1.901M
YoY Change	1.66%	-11.99%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$96.37M	$97.38M	$97.38M
YoY Change	-2.15%	-0.03%	-0.03%
Total Short-Term Liabilities	$141.3M	$142.2M	$142.2M
YoY Change	4.1%	3.97%	3.97%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.741M	$4.038M	$4.038M
YoY Change	-23.95%	-22.3%	-22.3%
Total Long-Term Liabilities	$3.741M	$0.00	$4.038M
YoY Change	-23.95%	-100.0%	-22.3%
TOTAL LIABILITIES
Total Short-Term Liabilities	$141.3M	$142.2M	$142.2M
Total Long-Term Liabilities	$3.741M	$0.00	$4.038M
Total Liabilities	$145.0M	$146.2M	$146.2M
YoY Change	3.12%	3.01%	3.01%
SHAREHOLDERS EQUITY
Retained Earnings	-$359.2M	-$356.4M
YoY Change	3.25%	2.36%
Common Stock	$231.6M	$231.6M
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$500.0K	$500.0K
YoY Change	0.0%	0.0%
Treasury Stock Shares	134.8M shares	134.8M shares
Shareholders Equity	-$128.1M	-$125.3M	-$125.3M
YoY Change
Total Liabilities & Shareholders Equity	$16.89M	$20.91M	$20.91M
YoY Change	-29.08%	-15.91%	-15.91%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$2.810M	-$3.353M	-$8.222M
YoY Change	-1118.12%	-77.97%	-44.97%
Depreciation, Depletion And Amortization	$12.00K	$43.00K	$52.00K
YoY Change	-70.0%	-59.43%	-35.0%
Cash From Operating Activities	$243.0K	$3.238M	-$4.311M
YoY Change	-105.26%	-4.2%	-262.68%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$99.00K
YoY Change	-100.0%	-100.0%	-36.13%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	$0.00	-$99.00K
YoY Change	-100.0%	-100.0%	-36.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.010M	-2.656M	$1.647M
YoY Change	-136.63%	40.6%	131.32%
NET CHANGE
Cash From Operating Activities	$243.0K	3.238M	-$4.311M
Cash From Investing Activities	0.000	0.000	-99.00K
Cash From Financing Activities	-1.010M	-2.656M	$1.647M
Net Change In Cash	-$767.0K	582.0K	-$2.763M
YoY Change	-83.4%	-60.76%	-182.18%
FREE CASH FLOW
Cash From Operating Activities	$243.0K	$3.238M	-$4.311M
Capital Expenditures	$0.00	$0.00	$99.00K
Free Cash Flow	$243.0K	$3.238M	-$4.410M
YoY Change	-105.25%	-4.43%	-276.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001590695
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-55181
CY2022	dei	Entity Registrant Name EntityRegistrantName	Twinlab Consolidated Holdings, Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3951742
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	4800 T-Rex Avenue, Suite 225
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Boca Raton
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33431
CY2022	dei	City Area Code CityAreaCode	561
CY2022	dei	Local Phone Number LocalPhoneNumber	443-4301
CY2022	dei	Security12g Title Security12gTitle	Common Stock
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	6111682000	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	259092833	shares
CY2022	dei	Auditor Firm AuditorFirmId	270
CY2022	dei	Auditor Name AuditorName	Tanner LLC
CY2022	dei	Auditor Location AuditorLocation	Lehi, Utah
CY2022Q4	us-gaap	Cash Cash	868000	usd
CY2021Q4	us-gaap	Cash Cash	3631000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4105000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6881000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	9407000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	5814000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	758000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1045000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	15138000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	17371000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	188000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	140000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4165000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5480000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	120000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	576000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1301000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1301000	usd
CY2022Q4	us-gaap	Assets Assets	20912000	usd
CY2021Q4	us-gaap	Assets Assets	24868000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6621000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6047000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1159000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1039000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	3708000	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	5422000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	33316000	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	26844000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	97381000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	142185000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1676000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	136760000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4038000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5197000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	146223000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	141957000	usd
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	393898884	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	393898884	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	394000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	394000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	231249000	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	231249000	usd
CY2022Q4	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	30000	usd
CY2021Q4	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	30000	usd
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	134806051	shares
CY2022Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	134806051	shares
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	500000	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	500000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-356424000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-348202000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-125311000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-117089000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24868000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	52584000	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	72089000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	38240000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	55511000	usd
CY2022	us-gaap	Gross Profit GrossProfit	14344000	usd
CY2021	us-gaap	Gross Profit GrossProfit	16578000	usd
CY2022	us-gaap	Selling Expense SellingExpense	3166000	usd
CY2021	us-gaap	Selling Expense SellingExpense	3416000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12809000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9736000	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	340000	usd
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	11118000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1971000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-7692000	usd
CY2022	us-gaap	Interest Expense InterestExpense	7902000	usd
CY2021	us-gaap	Interest Expense InterestExpense	8611000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1376000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7235000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8197000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14927000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	25000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-8222000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-14940000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	259092833	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	258837701	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	259092833	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	258837701	shares
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-102149000	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-14940000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-117089000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-8222000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-125311000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-8222000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-14940000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	168000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	457000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	941000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	890000	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	718000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	-565000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	-958000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	155000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-710000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1674000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1344000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-373000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-133000	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	340000	usd
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	11118000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2622000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2253000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3028000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1445000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-286000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1150000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	543000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	574000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1336000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1039000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-892000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	4758000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	2537000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4311000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2650000	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	72089000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	99000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	155000	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1344000	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	usd
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	632000	usd
CY2022	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	1647000	usd
CY2021	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1647000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	712000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2763000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3207000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3631000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	424000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	868000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3631000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	1434000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	1375000	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-weight: bold;"><span style="font-family: 'times new roman', times; font-size: 10pt;"><span style="font-weight: bold;">Note <span style="border-left: none; border-right: none;">1</span></span>–<span style="font-weight: bold;"> Nature of Business</span></span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;"> </span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;"><span style="font-style: italic;">Organization</span></span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;"> </span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;">Twinlab Consolidated Holdings, Inc. (the “Company”, “Twinlab,” “we,” “our” and “us”) was incorporated on October 24, 2013 under the laws of the State of Nevada as Mirror Me, Inc. On August 7, 2014, we amended our articles of incorporation and changed our name to Twinlab Consolidated Holdings, Inc.</span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;"> </span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;"><span style="font-style: italic;">Nature of Operations</span></span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;"> </span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;">We are an integrated marketer, distributor and retailer of branded nutritional supplements and other natural products sold to and through domestic health and natural food stores, mass market retailers, specialty store retailers, on-line retailers and websites. Internationally, we market and distribute branded nutritional supplements and other natural products to and through health and natural product distributors and retailers.</span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;"> </span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;">Our products include vitamins, minerals, specialty supplements and sports nutrition products sold under the Twinlab<span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">®</span> brand name, a market leader in the healthy aging and beauty from within categories sold under the Reserveage Nutrition and ResVitale® brand names; diet and energy products sold under the Metabolife<span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">®</span> brand name; and a full line of herbal teas sold under the Alvita<span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">®</span> brand name. To accommodate consumer preferences, our products come in various formulations and delivery forms, including capsules, tablets, softgels, chewables, liquids, sprays and powders. These products are sold primarily through health and natural food stores and on-line retailers, supermarkets, and mass-market retailers.</span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;"> </span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;">We also perform contract manufacturing services for private label products. Our contract manufacturing services business involves the manufacture of custom products to the specifications of a customer who requires finished products under the customer’s own brand name. We do not market these private label products as our business is to sell the products to the customer, who then markets and sells the products to retailers or end consumers.</span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;"> </span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;"><span style="font-style: italic;">Going Concern</span></span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;"> </span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;"><span>The accompanying consolidated financial statements have been prepared on a going concern basis, which assumes continuity of operations and realization of assets and liabilities in the ordinary course of business. In most periods since our formation, we have generated losses from operations. At December 31, 2022, we had an accumulated <span>defic<span>i<span>t of</span></span> $</span>356,424<span>. H</span>istorical losses are primarily attributable to lower than planned sales resulting from low fill rates on demand due to limitations of our working capital, delayed product introductions and postponed marketing activities, merger-related and other restructuring costs, and interest and refinancing charges associated with our debt refinancing, and impairment of our goodwill and intangible assets. Losses have been funded primarily through issuance of common stock and third-party or related party debt.</span></span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;"> </span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;"><span>Additionally, the Company is closely monitoring the impact of the world events and wide spread health issues, or pandemics on all aspects of its business and geographies, including how it will impact its customers and business partners. While the Company did not incur significant disruptions during the year ended December 31, 2022 from the COVID-19 pandemic, it is unable to predict the impact that future pandemics, inflation, and other world events could have on its financial condition, results of operations and cash flows due to numerous uncertainties.</span></span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;"> </span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;"><span>Because of our history of operating losses and significant interest expense on our debt, we have a working capital deficiency of $127,047 at December 31, 2022.</span><span> We also have $97,381 of debt, presented in current liabilities. These continuing conditions, among others, raise substantial doubt about our ability to continue as a going concern.</span></span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;"> </span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;">Management is addressing operating issues through the following actions: focusing on growing the core business and brands; continuing emphasis on major customers and key products; reducing manufacturing and operating costs and continuing to negotiate lower prices from major suppliers. We believe that we will need additional capital to execute our business plan. If additional funding is required, there can be no assurance that sources of funding will be available when needed on acceptable terms or at all.</span></p>
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-356424000	usd
CY2022Q4	tlcc	Working Capital Deficiency WorkingCapitalDeficiency	-127047000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	97381000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;"><span style="font-style: italic;">Use of Estimates </span></span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;"> </span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant management estimates include those with respect to returns and allowances, allowance for doubtful accounts, reserves for inventory obsolescence, the recoverability of long-lived assets, intangibles and goodwill.</span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;"><br/></span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt;"><span style="font-family: 'times new roman', times; font-size: 10pt; font-style: italic;">Revenue Recognition</span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;"><br/></span></p><p style="margin: 0pt; text-align: justify; font-size: 11pt; font-family: Calibri, sans-serif;"><span style="font-family: 'times new roman', times; font-size: 10pt;">The Company recognizes revenue based on a five-step model in accordance with Accounting Standards Codification ("ASC") 606. For our customer contracts, (i) we identify the contract with a customer, (ii) we identify the performance obligations in the contract, (iii) we determine the transaction price, (iv) we allocate the transaction price to the performance obligation; and (v) we recognize revenue when we satisfy the performance obligation. Our revenues are recorded at a point in time when the performance is fulfilled, which is when the product is shipped to or received by the customer.</span></p><p style="margin: 0pt; text-align: justify; font-size: 11pt; font-family: Calibri, sans-serif;"><span style="font-family: 'times new roman', times; font-size: 10pt;"> </span></p><p style="margin: 0pt; text-align: justify; font-size: 11pt; font-family: Calibri, sans-serif;"><span style="font-family: 'times new roman', times; font-size: 10pt;">Product sales are recorded net of variable considerations, such as provisions for returns, discounts and allowances. </span><span style="font-size: 12pt; font-family: Cambria, serif; margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">We account for shipping and handling costs as costs to fulfill a contract and not as performance obligations to our customers. </span></span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt;"><br/></p>
CY2022Q4	tlcc	Contract With Customer Deposit Liability Current ContractWithCustomerDepositLiabilityCurrent	1856000	usd
CY2021Q4	tlcc	Contract With Customer Deposit Liability Current ContractWithCustomerDepositLiabilityCurrent	2104000	usd
CY2022Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	45000	usd
CY2021Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	56000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1901000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2160000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	52584000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	1546000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	534000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	1391000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	511000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	120000	usd
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	120000	usd
CY2021	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2022	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	223000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	788000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	9407000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-8222000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-14940000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	259092833	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	258837701	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	259092833	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	258837701	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;"><span style="font-style: italic;">Significant Concentration of Credit Risk</span></span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;"> </span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;">The Company maintains its cash in bank deposit accounts which, at times, exceed federally insured limits. To date, the Company has not experienced a loss or lack of access to its invested cash; however, no assurance can be provided that access to the Company's invested cash will not be impacted by adverse conditions in the financial markets.</span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;"> </span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;"><span>Sales to our top three customers aggregated to approximately 21% and 26% of total consolidated sales in 2022 and 2021, respectively. Sales to one of those customers were approximately 8% and 11% of total sales in 2022 and 2021, respectively. Accounts receivable from these customers were approximately 28% and 22% of total accounts receivable as of December 31, 2022 and 2021, respectively.</span></span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;"><span><br/></span></span></p><p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;"><span>Our two major vendors accounted for 36% and 46% of purchases for the year ended December 31, 2022 and 2021, respectively. A third vendor represented an additional 11% of purchases for each of the years ended December 31, 2022 and 2021.</span></span></p>
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	906000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2016000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	8724000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4586000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	9630000	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	6602000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	5814000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	310000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	212000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	122000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	72000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	188000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	140000	usd
CY2022	us-gaap	Depreciation Depreciation	52000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	120000	usd
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	120000	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	10882000	usd
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	11222000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	10762000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	10646000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	120000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	576000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	116000	usd
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	11118000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	97381000	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	97408000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	97381000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	97408000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2016Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	2500000	usd
CY2016Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.085	pure
CY2020Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	6034702	shares
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.07
CY2021	tlcc	Class Of Warrant Or Right Granted During Period Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightGrantedDuringPeriodNumberOfSecuritiesCalledByWarrantsOrRights	0	shares
CY2021	tlcc	Class Of Warrant Or Right Granted During Period Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightGrantedDuringPeriodExercisePriceOfWarrantsOrRights	0
CY2021	tlcc	Class Of Warrant Or Right Cancelled During Period Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightCancelledDuringPeriodNumberOfSecuritiesCalledByWarrantsOrRights	500000	shares
CY2021	tlcc	Class Of Warrant Or Right Canceled During Period Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightCanceledDuringPeriodExercisePriceOfWarrantsOrRights	0
CY2021	tlcc	Class Of Warrant Or Right Exercised During Period Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightExercisedDuringPeriodNumberOfSecuritiesCalledByWarrantsOrRights	1034702	shares
CY2021	tlcc	Class Of Warrant Or Right Exercised During Period Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisedDuringPeriodExercisePriceOfWarrantsOrRights	0
CY2021Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	4500000	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01
CY2022	tlcc	Class Of Warrant Or Right Granted During Period Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightGrantedDuringPeriodNumberOfSecuritiesCalledByWarrantsOrRights	0	shares
CY2022	tlcc	Class Of Warrant Or Right Granted During Period Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightGrantedDuringPeriodExercisePriceOfWarrantsOrRights	0
CY2022	tlcc	Class Of Warrant Or Right Cancelled During Period Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightCancelledDuringPeriodNumberOfSecuritiesCalledByWarrantsOrRights	0	shares
CY2022	tlcc	Class Of Warrant Or Right Canceled During Period Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightCanceledDuringPeriodExercisePriceOfWarrantsOrRights	0
CY2022	tlcc	Class Of Warrant Or Right Exercised During Period Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightExercisedDuringPeriodNumberOfSecuritiesCalledByWarrantsOrRights	0	shares
CY2022	tlcc	Class Of Warrant Or Right Exercised During Period Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisedDuringPeriodExercisePriceOfWarrantsOrRights	0
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	4500000	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01
CY2021	tlcc	Class Of Warrant Or Right Exercised During Period Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightExercisedDuringPeriodNumberOfSecuritiesCalledByWarrantsOrRights	1034702	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	7194412	shares
CY2022Q4	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	1528384	shares
CY2022Q4	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	30000	usd
CY2022Q4	tlcc	Subscription Receivable Annual Interest Rate SubscriptionReceivableAnnualInterestRate	0.05	pure
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	61352000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	25000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	13000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	25000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	13000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-900000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2841000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	416000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-957000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	484000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3798000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	25000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1723000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3135000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	321000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-770000	usd
CY2022	tlcc	Income Tax Reconciliation Interest Expense IncomeTaxReconciliationInterestExpense	0	usd
CY2021	tlcc	Income Tax Reconciliation Interest Expense IncomeTaxReconciliationInterestExpense	38000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	0	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	82000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	484000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3798000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	943000	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	25000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	61053000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	9408000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	7949000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	5530000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	5925000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	2877000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	3456000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3064000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2766000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	81932000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	81448000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	81932000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	81448000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	484000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3798000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	usd
CY2021Q4	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	31000
CY2022	us-gaap	Lease Cost LeaseCost	895000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	211000	usd
CY2021	us-gaap	Lease Cost LeaseCost	874000	usd
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	325000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1534000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1524000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1566000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1150000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	306000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	6080000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	883000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5197000	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	725000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	1505000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y10M24D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0825	pure
CY2022	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	1073000	usd
CY2021	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	1910000	usd

Files In Submission

Name	View Source	Status
0001753926-23-000347-index-headers.html	Edgar Link	pending
0001753926-23-000347-index.html	Edgar Link	pending
0001753926-23-000347.txt	Edgar Link	pending
0001753926-23-000347-xbrl.zip	Edgar Link	pending
ex10179_1.htm	Edgar Link	pending
ex211_2.htm	Edgar Link	pending
ex231_3.htm	Edgar Link	pending
ex311_4.htm	Edgar Link	pending
ex321_5.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img398d836b98d84f2a929c.jpg	Edgar Link	pending
img4201d3a06a414e328099.jpg	Edgar Link	pending
imga47cd5145011415abd91.jpg	Edgar Link	pending
imgbadf4203471644a89608.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tlcc-20221231.htm	Edgar Link	pending
tlcc-20221231.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
tlcc-20221231_cal.xml	Edgar Link	unprocessable
tlcc-20221231_def.xml	Edgar Link	unprocessable
tlcc-20221231_lab.xml	Edgar Link	unprocessable
tlcc-20221231_pre.xml	Edgar Link	unprocessable
tlcc-20221231_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TLCC
Twinlab Consolidated Holdings Inc Stock $tlcc

2023 Q1 Form 10-K Financial Statement

#000175392623000347 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TLCC Twinlab Consolidated Holdings Inc Stock $tlcc

2023 Q1 Form 10-K Financial Statement

#000175392623000347 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TLCC
Twinlab Consolidated Holdings Inc Stock $tlcc